Authors:
SILVERS D
KIPNES M
BROADSTONE V
PATTERSON D
QUIGLEY EMM
MCCALLUM R
LEIDY NK
FARUP C
LIU Y
JOSLYN A
Citation: D. Silvers et al., DOMPERIDONE IN THE MANAGEMENT OF SYMPTOMS OF DIABETIC GASTROPARESIS -EFFICACY, TOLERABILITY, AND QUALITY-OF-LIFE OUTCOMES IN A MULTICENTERCONTROLLED TRIAL, Clinical therapeutics, 20(3), 1998, pp. 438-453
Citation: R. Siddique et al., COST OF HOSPITALIZATIONS FOR DIABETIC-PATIENTS WITH VOMITING - EVIDENCE FROM A NATIONAL SURVEY, Gastroenterology, 114(4), 1998, pp. 168-168
Citation: R. Siddioue et al., COST OF HOSPITALIZATIONS FOR DIABETIC-PATIENTS WITH VOMITING - EVIDENCE FROM A NATIONAL SURVEY, Diabetes, 47, 1998, pp. 727-727
Authors:
LIM D
FARUP C
LAWRENCE BJ
SORRELL L
DUBOIS RW
ZELDIS JB
Citation: D. Lim et al., GASTROINTESTINAL ILLNESS IN MANAGED CARE - HEALTH-CARE UTILIZATION AND COSTS, American journal of managed care, 3(12), 1997, pp. 1859-1872
Citation: C. Farup et al., A NEW SCALE FOR SYMPTOM ASSESSMENT IN PATIENTS WITH GASTROESOPHAGEAL REFLUX DISEASE (GERD) AND ASSOCIATED UPPER GASTROINTESTINAL (UGI) SYMPTOMS, Gastroenterology, 112(4), 1997, pp. 14-14
Authors:
QUIGLEY E
LEIDY NK
MURRAY M
SILVERS D
KIPNES M
BROADSTONE V
PATTERSON D
MCCALLUM R
FARUP C
Citation: E. Quigley et al., DOMPERIDONE IMPROVES HEALTH-RELATED QUALITY-OF-LIFE (HRQOL) IN PATIENTS WITH GASTROINTESTINAL SYMPTOMS ASSOCIATED WITH DIABETIC GASTROPARESIS, Gastroenterology, 112(4), 1997, pp. 36-36